MMapap 3-15_YellowFever_Africa_YB2016_v4.pdf3-15_YellowFever_Africa_YB2016_v4.pdf 1 1/23/20151/23/2015 11:04:2411:04:24 AMAM
WESTERN ALGERIA LIBYA EGYPT Riyadh SAHARA SAUDI ARABIA MAURITANIA MALI Nouakchott Arlit OMAN Aleg Tidjikdja Timbuktu Kidal SUDAN CAPE VERDE Agadez NIGER Nema Gao Khartoum ERITREA YEMEN Praia SENEGAL CHAD Asmara Sanaa Dakar BURKINA Niamey Mao El Fasher Banjul Bamako FASO Abeche GAMBIA Bissau El Obeid DJIBOUTI Ouagadougou Ndjamena GUINEA-BISSAU GUINEA Addis Djibouti CÔTE BENIN NIGERIA Ababa Conakry Freetown SOMALIA D’IVOIRE TOGO Abuja SOUTH SIERRA LEONE Yamoussoukro ETHIOPIA Monrovia GHANA Cotonou CEN AFR REP SUDAN Lome CAMEROON LIBERIA Accra Bangui Juba Malabo Yaoundé Mogadishu EQ GUINEA DEM REP UGANDA São Tomé Libreville REP OF CONGO Kampala KENYA OF SÃO TOMÉ GABON RWANDA Kigali Nairobi CONGO Bujumbura AND Brazzaville PRINCIPE BURUNDI Kinshasa TANZANIA Dar es Salaam Luanda Moroni ANGOLA MALAWI COMOROS ZAMBIA Lilongwe Lusaka MOZAMBIQUE Harare Vaccination recommended ZIMBABWE Antananarivo Vaccination generally not NAMIBIA recommended1 BOTSWANA MADAGASCAR Vaccination not recommended Windhoek Gaborone YELLOW FEVER VACCINE RECOMMENDATIONS IN AFRICA2 1 Yellow fever (YF) vaccination is generally not recommended in areas where there is low potential for YF virus exposure. However, vaccination might be considered for a small subset of travelers to these areas who are at increased risk for exposure to YF virus because of prolonged travel, heavy exposure to mosquitoes, or inability to avoid mosquito bites. Consideration for vaccination of any traveler must take into account the traveler’s risk of being infected with YF virus, country entry requirements, and individual risk factors for serious vaccine-associated adverse events (e.g., age, immune status). 2 Current as of September 2014. This map, which aligns with recommendations also published by the World Health Organization (WHO), is an updated version of the 2010 map created by the Informal WHO Working Group on the Geographic Risk of Yellow Fever.